Ignite Creation Date:
2024-05-06 @ 3:02 AM
Last Modification Date:
2024-10-26 @ 11:27 AM
Study NCT ID:
NCT02187783
Status:
COMPLETED
Last Update Posted:
2019-07-18
First Post:
2014-07-09
Brief Title:
LEE011 for Patients With CDK46 Pathway Activated Tumors SIGNATURE
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-08-25
Start Date Type:
ACTUAL
Primary Completion Date:
2018-01-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-01-17
Completion Date Type:
ACTUAL
First Submit Date:
2014-07-09
First Submit QC Date:
July 9 2014
Study First Post Date:
2014-07-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2019-04-16
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-07-16
Last Update Post Date:
2019-07-18
Last Update Post Date Type:
ACTUAL